E2F1 expression was positive in 95.56% (86/90) of SCLC, 50% (5/10) of large lung cancer cell (LCLC), and 10% (2/20) of adenocarcinoma samples compared with the normal alveolar sections. This evidence concerns the gene E2F1 and lung carcinoma.